|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
China Animal Healthcare Ltd
Main Activities: Pharmaceutical and Medicine Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name China Animal Healthcare Ltd Headquarters 1802 Shatin Galleria, 18-24 Shan Mei Street; Hamilton ; Hamilton Legal Address Clarendon House, 2 Church Street; Hamilton ; Hamilton; HM11 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational ISIN CODE : BMG211151037 Financial Auditors: Moore Stephens Certified Public Accountants (2000) Incorporation Date: August 10, 2000 Total Employees: 194 Tel: (852) 23669013 |
|
Company Description |
| The Group is a leading animal drug manufacturer focusing on the manufacture, sale and distribution of compound chemical drugs (comprising powdered drugs and injection drugs) and biological drugs (comprising Mandatory Vaccines and non-Mandatory Vaccines) for poultry and livestock in the PRC. The Group also produces additives a lesser extent. Based in the PRC, China Animal Healthcare Ltd. is a leading animal drug manufacturer focusing on the manufacture, sale and distribution of compound chemical | ||
|
||
Company Analysis |
| According to the Consolidated - Non-Audited financial statement for the first two cumulated quarters of 2011, total net operating revenues increased with 36.29%, from CNY 253,460 thousands to CNY 345,445 thousands. Operating result increased from CNY 106,503 thousands to CNY 164,570 thousands which means 54.52% change. The results of the period increased 53.95% reaching CNY 119,680 thousands at the end of the period against CNY 77,740 thousands last year. Return on equity (Net income/Total equity) went from 9.79% to 12.26%, the Return On Asset (Net income / Total Asset) went from 6.11% to 6.94% and the Net Profit Margin (Net Income/Net Sales) went from 30.67% to 34.65% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 54.47% compared to 38.87% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.74 to 5.56 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2011 Q2C (cons) |
2011 Q1 (cons) |
|
 | ||
| Non-Audited | Non-Audited | |
| ||
| CEIC Company Financials (New) | CEIC Company Financials (New) | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
1,723,591 |
1,672,251 |
| ||
Current Assets |
728,842 |
657,948 |
| ||
Total Liabilities |
531,698 |
511,662 |
| ||
Shareholders Equity |
1,191,893 |
1,160,589 |
| ||
Current Liabilities |
131,076 |
103,821 |
| ||
| * All the accounts are in CNY. | ||
Income Statement
| ||
Total Operating Revenue |
379,556 |
156,267 |
| ||
Operational Profit (Loss) |
164,570 |
69,849 |
| ||
Net Profit (Loss) |
118,472 |
58,260 |
| ||
| * All the accounts are in CNY. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
6.94% |
3.19% |
| ||
Annualised Return on Assets (ROA) |
13.88% |
12.76% |
| ||
Return on Equity (ROE) |
12.26% |
5.61% |
| ||
Annualised Return on Equity (ROE) |
24.52% |
22.44% |
| ||
Return on Sales (ROS) |
47.64% |
53.18% |
| ||
Return on Capital |
7.44% |
3.71% |
| ||
Gross Profit Margin |
72.93% |
75.96% |
| ||
Operating Profit Margin |
34.3% |
44.36% |
| Efficiency Ratios | ||
| ||
Inventory Turnover |
0.03x |
0.02x |
| ||
Current asset turnover |
0.00x |
0.00x |
| ||
Fixed-asset turnover |
0.02x |
0.01x |
| ||
Asset Turnover |
0.00x |
0.00x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
164,570 |
69,849 |
| ||
EBITDA |
200,221 |
80,085 |
| ||
Enterprise value |
342,333 |
383,569 |
| ||
Enterprise Value / EBITDA |
1.71 |
4.79 |
| ||
Bookvalue (BV) |
976,045 |
950,844 |
| ||
Net Cash |
559,816 |
550,400 |
| Liquidity Ratios | ||
| ||
Current Ratio |
5.56% |
6.34% |
| ||
Quick ratio |
5.25% |
6.12% |
| ||
Doom's day ratio |
4.41% |
5.47% |
| ||
Cash Flow to Debt |
4.15% |
19.44% |
| Leverage Ratios | ||
| ||
Leverage ratio |
1.77% |
1.76% |
| ||
Interest Coverage Ratio |
13.97% |
12.48% |
| ||
Debt to equity |
54.47% |
53.81% |
| ||
Debt to total assets |
0.17% |
0.17% |
| ||
Long Term Debt to Capital |
0.24% |
0.25% |
| ||
Debt / Enterprise Value |
0.84% |
0.75% |
| Market ratios | ||
| ||
Market Capitalization/EBITDA |
11.47 |
31.38 |
| ||
Price/Book Ratio |
2.14 |
2.38 |
| ||
Market Cap / Net cash |
4.10 |
4.57 |
| ||
Market cap/Shareholder equity |
2.35 |
2.64 |
| Trend Ratios | ||
| ||
Net Income Trend |
1.58% |
1.59% |
| ||
Operating Income Trend |
1.55% |
1.42% |
| ||
 |